“With the scramble for viral and antibody testing kits, and the ultimate goal of finding a vaccine for Covid-19, many biotech companies are suddenly in the spotlight. Even those that aren’t directly working on a Covid-related solution look more attractive,” observes the author of today’s article, who also singles out biotech stocks as being the one possible bright spot in the current, challenging market environment. For seven biotech stocks he highlights as particularly well positioned for a nice payoff, CLICK HERE.